Telix Pharmaceuticals Revenue

In the year 2023, Telix Pharmaceuticals had annual revenue of 496.66M AUD with 210.23% growth. Revenue in the quarter ending December 31, 2023 was 281.71M AUD with 5,911.80% year-over-year growth.

Revenue (ttm)

502.55M

Revenue Growth

+6,515.94%

P/S Ratio

12.10

Revenue / Employee

1,210,957

Employees

415

Market Cap

6.12B AUD

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	496.66M	336.56M	210.23%
Dec 31, 2022	160.10M	152.50M	2,007.64%
Dec 31, 2021	7.60M	2.38M	45.71%
Dec 31, 2020	5.21M	1.73M	49.58%
Dec 31, 2019	3.49M	3.29M	1,685.88%
Dec 31, 2018	195.14K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	31.80B
ResMed Inc.	6.65B
Cochlear Limited	2.18B
Fisher & Paykel Healthcare Corporation Limited	1.60B
Pro Medicus Limited	142.12M
Sonic Healthcare Limited	8.21B
Ramsay Health Care Limited	15.96B
Neuren Pharmaceuticals Limited	231.93M

Revenue Rankings

Telix Pharmaceuticals News

14 days ago - Telix Pharma Stock: Prostate Cancer Treatments Could Lead To Increased Value - Seeking Alpha
18 days ago - Telix Pharma pulls U.S. IPO citing market conditions - Seeking Alpha
27 days ago - Telix Announces Launch of Proposed Initial Public Offering in the United States - GlobeNewsWire
6 weeks ago - Telix Files Registration Statement for Proposed Initial Public Offering in the United States - GlobeNewsWire
2 months ago - Telix Pharmaceuticals reports Q1 results - Seeking Alpha
2 months ago - Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc. - Business Wire
4 months ago - Telix Pharmaceuticals Ltd Grand Pharma Investor Webinar Transcript - GuruFocus
4 months ago - Telix Pharmaceuticals Limited (TLPPF) Q4 2023 Earnings Call Transcript - Seeking Alpha

More News